Opinion: Two Steps Toward Establishing Priority of Discovery

Establishing priority of a new finding is best achieved through a combination of a rapid, scientist-controlled disclosure followed by subsequent validation, through journal-based peer review and other mechanisms.

Written byRonald Vale and Anthony Hyman
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

PIXABAY, GERALTA scientist conducts experiments, analyzes the data from these experiments, and then arrives at a new understanding of the natural world. Once confident of their discovery, the scientist will then transmit this new knowledge to the rest of the scientific community. If the work is original and the evidence is accurate and compelling, it is expected that other scientists will give credit to the scientist who made the original discovery. However, this process of establishing “priority” for the discovery is not straightforward and disputes over priority have permeated every epoch of modern science.

With many more scientists on the planet, all accessing the same information and many seeking to answer reasonably evident next questions, competitive situations arise more frequently. Furthermore, the speed of global communication has increased dramatically. These changes in science and communication technologies have led us to revisit two questions: How should a new discovery be communicated, and how should priority be established?

When a scientist makes a discovery, at that moment, it belongs to the scientist and no one else. However, while this private eureka moment is a thrilling experience, exclusive ownership of the discovery is of little value, as it neither advances the scientist’s reputation nor serves science as a whole. Thus, the scientist must eventually disclose the discovery and transfer the property to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies